本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Therapix Biosciences Ltd.

0.3170
0.0000
成交量:- -
成交額:- -
市值:181.31萬
市盈率:-0.11
高:0.3170
開:0.3170
低:0.3170
收:0.3170
資料載入中...
2020/06/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/02

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/04/30

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/03/31

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/30

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/26

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/03/24

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/19

[修訂]招股説明書

[Amend] Registration statement for certain foreign private issuers
2020/03/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/31

招股説明書

Registration statement for certain foreign private issuers
2020/01/22

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/08

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/02

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/11

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]